Literature DB >> 11266293

Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis.

A Guiyoule1, G Gerbaud, C Buchrieser, M Galimand, L Rahalison, S Chanteau, P Courvalin, E Carniel.   

Abstract

Plasmid-mediated high-level resistance to multiple antibiotics was reported in a clinical isolate of Yersinia pestis in Madagascar in 1997. We describe a second Y. pestis strain with high-level resistance to streptomycin, isolated from a human case of bubonic plague in Madagascar. The resistance determinants were carried by a self-transferable plasmid that could conjugate at high frequencies to other Y. pestis isolates. The plasmid and the host bacterium were different from those previously associated with multiple-drug resistance, indicating that acquisition of resistance plasmids is occurring in this bacterial species. Emergence of resistance to streptomycin in Y. pestis represents a critical public health problem since this antibiotic is used as the first-line treatment against plague in many countries.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11266293      PMCID: PMC2631670          DOI: 10.3201/eid0701.010106

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  13 in total

1.  Aminoglycoside-modifying enzymes.

Authors:  M J Haas; J E Dowding
Journal:  Methods Enzymol       Date:  1975       Impact factor: 1.600

2.  Multidrug resistance in Yersinia pestis mediated by a transferable plasmid.

Authors:  M Galimand; A Guiyoule; G Gerbaud; B Rasoamanana; S Chanteau; E Carniel; P Courvalin
Journal:  N Engl J Med       Date:  1997-09-04       Impact factor: 91.245

3.  Host specificity of DNA produced by Escherichia coli: bacterial mutations affecting the restriction and modification of DNA.

Authors:  W B Wood
Journal:  J Mol Biol       Date:  1966-03       Impact factor: 5.469

4.  Plasmids in Yersinia pestis.

Authors:  D M Ferber; R R Brubaker
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

5.  Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

Authors:  C Yanisch-Perron; J Vieira; J Messing
Journal:  Gene       Date:  1985       Impact factor: 3.688

6.  In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.

Authors:  J A Frean; L Arntzen; T Capper; A Bryskier; K P Klugman
Journal:  Antimicrob Agents Chemother       Date:  1996-11       Impact factor: 5.191

7.  Nucleotide sequence analysis of a transposon (Tn5393) carrying streptomycin resistance genes in Erwinia amylovora and other gram-negative bacteria.

Authors:  C S Chiou; A L Jones
Journal:  J Bacteriol       Date:  1993-02       Impact factor: 3.490

8.  Complete sequence of the IncPbeta plasmid R751: implications for evolution and organisation of the IncP backbone.

Authors:  P B Thorsted; D P Macartney; P Akhtar; A S Haines; N Ali; P Davidson; T Stafford; M J Pocklington; W Pansegrau; B M Wilkins; E Lanka; C M Thomas
Journal:  J Mol Biol       Date:  1998-10-09       Impact factor: 5.469

9.  Complete nucleotide sequence and gene organization of the broad-host-range plasmid RSF1010.

Authors:  P Scholz; V Haring; B Wittmann-Liebold; K Ashman; M Bagdasarian; E Scherzinger
Journal:  Gene       Date:  1989-02-20       Impact factor: 3.688

10.  Expression of the strA-strB streptomycin resistance genes in Pseudomonas syringae and Xanthomonas campestris and characterization of IS6100 in X. campestris.

Authors:  G W Sundin; C L Bender
Journal:  Appl Environ Microbiol       Date:  1995-08       Impact factor: 4.792

View more
  100 in total

1.  Biological Warfare: Implications for Antimicrobial Use.

Authors:  Ethan Rubinstein; Itzhak Levi
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

2.  Synergistic protection of mice against plague with monoclonal antibodies specific for the F1 and V antigens of Yersinia pestis.

Authors:  Jim Hill; Catherine Copse; Sophie Leary; Anthony J Stagg; E Diane Williamson; Richard W Titball
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

3.  Chemical scaffolds with structural similarities to siderophores of nonribosomal peptide-polyketide origin as novel antimicrobials against Mycobacterium tuberculosis and Yersinia pestis.

Authors:  Julian A Ferreras; Akash Gupta; Neal D Amin; Arijit Basu; Barij N Sinha; Stefan Worgall; Venkatesan Jayaprakash; Luis E N Quadri
Journal:  Bioorg Med Chem Lett       Date:  2011-08-26       Impact factor: 2.823

4.  Vaccination with live Yersinia pestis primes CD4 and CD8 T cells that synergistically protect against lethal pulmonary Y. pestis infection.

Authors:  Alexander V Philipovskiy; Stephen T Smiley
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

5.  Protein microarray for profiling antibody responses to Yersinia pestis live vaccine.

Authors:  Bei Li; Lingxiao Jiang; Qifeng Song; Junxin Yang; Zeliang Chen; Zhaobiao Guo; Dongsheng Zhou; Zongmin Du; Yajun Song; Jin Wang; Hongxia Wang; Shouyi Yu; Jian Wang; Ruifu Yang
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

6.  Administration of antibody to the lung protects mice against pneumonic plague.

Authors:  Jim Hill; Jim E Eyles; Stephen J Elvin; Gareth D Healey; Roman A Lukaszewski; Richard W Titball
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

Review 7.  Resistance of Yersinia pestis to antimicrobial agents.

Authors:  Marc Galimand; Elisabeth Carniel; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

Review 8.  Intraspecific diversity of Yersinia pestis.

Authors:  Andrey P Anisimov; Luther E Lindler; Gerald B Pier
Journal:  Clin Microbiol Rev       Date:  2004-04       Impact factor: 26.132

9.  An age-old paradigm challenged: old baboons generate vigorous humoral immune responses to LcrV, a plague antigen.

Authors:  Sue Stacy; Amanda Pasquali; Valerie L Sexton; Angelene M Cantwell; Ellen Kraig; Peter H Dube
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

10.  A non-invasive in vivo imaging system to study dissemination of bioluminescent Yersinia pestis CO92 in a mouse model of pneumonic plague.

Authors:  Jian Sha; Jason A Rosenzweig; Michelle L Kirtley; Christina J van Lier; Eric C Fitts; Elena V Kozlova; Tatiana E Erova; Bethany L Tiner; Ashok K Chopra
Journal:  Microb Pathog       Date:  2012-10-09       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.